Cumberland Pharmaceuticals (CPIX) Non-Current Deferred Tax Liability (2011)

Cumberland Pharmaceuticals' (CPIX) quarterly Non-Current Deferred Tax Liability came in at $645029.0 in Q4 2011.

Cumberland Pharmaceuticals (CPIX) Non-Current Deferred Tax Liability (2011) Analysis & Trends

Cumberland Pharmaceuticals has disclosed Non-Current Deferred Tax Liability across 1 years of filings, most recently posting $645029.0 for Q4 2011.

Non-Current Deferred Tax Liability for Q4 2011 came in at $645029.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2011 was $645029.0 (changed N/A YoY), and the FY2011 annual result was $645029.0, changed N/A from the prior year.
Non-Current Deferred Tax Liability came in at $645029.0 for Q4 2011 at Cumberland Pharmaceuticals.
In the past five years, Non-Current Deferred Tax Liability ranged from a high of $645029.0 in Q4 2011 to a low of $645029.0 in Q4 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn
10	Cumberland Pharmaceuticals	86.62 Mn	75.28 Mn	7.20 Mn

Download Data

Date	Value
Dec 31, 2011	645,029.00
Dec 31, 2011	645,029.00